NANOG and breast carcinoma: In breast cancer cells, Han and colleagues found that knockdown of Nanog resulted in inhibited cell proliferation, G0/G1 arrest of the cell cycle, and suppressed expression of cyclin D1 and oncogene c-Myc [29].